CD40LG and Alzheimer disease: At the transcriptomic level, we identified a notable increase (uncorrected P < 0.01) in CD40L expression in PBMCs derived from both ε3ε4 and ε4ε4-carrying AD patients, relative to ε3ε3 AD patients.